title: Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.
abstract: BACKGROUND
  Autologous hematopoietic stem cell transplantation (HSCT) of gene-modified cells is an alternative to enzyme replacement therapy (ERT) and allogeneic HSCT that has shown clinical benefit for adenosine deaminase-deficient (ADA-deficient) SCID when combined with reduced intensity conditioning (RIC) and ERT cessation. Clinical safety and therapeutic efficacy were evaluated in a phase II study.
  
  
  METHODS
  Ten subjects with confirmed ADA-deficient SCID and no available matched sibling or family donor were enrolled between 2009 and 2012 and received transplantation with autologous hematopoietic CD34+ cells that were modified with the human ADA cDNA (MND-ADA) γ-retroviral vector after conditioning with busulfan (90 mg/m2) and ERT cessation. Subjects were followed from 33 to 84 months at the time of data analysis. Safety of the procedure was assessed by recording the number of adverse events. Efficacy was assessed by measuring engraftment of gene-modified hematopoietic stem/progenitor cells, ADA gene expression, and immune reconstitution.
  
  
  RESULTS
  With the exception of the oldest subject (15 years old at enrollment), all subjects remained off ERT with normalized peripheral blood mononuclear cell (PBMC) ADA activity, improved lymphocyte numbers, and normal proliferative responses to mitogens. Three of nine subjects were able to discontinue intravenous immunoglobulin replacement therapy. The MND-ADA vector was persistently detected in PBMCs (vector copy number [VCN] = 0.1-2.6) and granulocytes (VCN = 0.01-0.3) through the most recent visits at the time of this writing. No patient has developed a leukoproliferative disorder or other vector-related clinical complication since transplant.
  
  
  CONCLUSIONS
  These results demonstrate clinical therapeutic efficacy from gene therapy for ADA-deficient SCID, with an excellent clinical safety profile.
  
  
  BACKGROUND
  ClinicalTrials.gov NCT00794508.
  
  
  BACKGROUND
  Food and Drug Administration Office of Orphan Product Development award, RO1 FD003005; NHLBI awards, PO1 HL73104 and Z01 HG000122; UCLA Clinical and Translational Science Institute awards, UL1RR033176 and UL1TR000124.
authors.forename: Kit L
authors.initials: KL
authors.lastname: Shaw
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Garabedian
authors.forename: Suparna
authors.initials: S
authors.lastname: Mishra
authors.forename: Provaboti
authors.initials: P
authors.lastname: Barman
authors.forename: Alejandra
authors.initials: A
authors.lastname: Davila
authors.forename: Denise
authors.initials: D
authors.lastname: Carbonaro
authors.forename: Sally
authors.initials: S
authors.lastname: Shupien
authors.forename: Christopher
authors.initials: C
authors.lastname: Silvin
authors.forename: Sabine
authors.initials: S
authors.lastname: Geiger
authors.forename: Barbara
authors.initials: B
authors.lastname: Nowicki
authors.forename: E Monika
authors.initials: EM
authors.lastname: Smogorzewska
authors.forename: Berkley
authors.initials: B
authors.lastname: Brown
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Wang
authors.forename: Satiro
authors.initials: S
authors.lastname: de Oliveira
authors.forename: Yeong
authors.initials: Y
authors.lastname: Choi
authors.forename: Alan
authors.initials: A
authors.lastname: Ikeda
authors.forename: Dayna
authors.initials: D
authors.lastname: Terrazas
authors.forename: Pei-Yu
authors.initials: PY
authors.lastname: Fu
authors.forename: Allen
authors.initials: A
authors.lastname: Yu
authors.forename: Beatriz Campo
authors.initials: BC
authors.lastname: Fernandez
authors.forename: Aaron R
authors.initials: AR
authors.lastname: Cooper
authors.forename: Barbara
authors.initials: B
authors.lastname: Engel
authors.forename: Greg
authors.initials: G
authors.lastname: Podsakoff
authors.forename: Arumugam
authors.initials: A
authors.lastname: Balamurugan
authors.forename: Stacie
authors.initials: S
authors.lastname: Anderson
authors.forename: Linda
authors.initials: L
authors.lastname: Muul
authors.forename: G Jayashree
authors.initials: GJ
authors.lastname: Jagadeesh
authors.forename: Neena
authors.initials: N
authors.lastname: Kapoor
authors.forename: John
authors.initials: J
authors.lastname: Tse
authors.forename: Theodore B
authors.initials: TB
authors.lastname: Moore
authors.forename: Ken
authors.initials: K
authors.lastname: Purdy
authors.forename: Radha
authors.initials: R
authors.lastname: Rishi
authors.forename: Kathey
authors.initials: K
authors.lastname: Mohan
authors.forename: Suzanne
authors.initials: S
authors.lastname: Skoda-Smith
authors.forename: David
authors.initials: D
authors.lastname: Buchbinder
authors.forename: Roshini S
authors.initials: RS
authors.lastname: Abraham
authors.forename: Andrew
authors.initials: A
authors.lastname: Scharenberg
authors.forename: Otto O
authors.initials: OO
authors.lastname: Yang
authors.forename: Kenneth
authors.initials: K
authors.lastname: Cornetta
authors.forename: David
authors.initials: D
authors.lastname: Gjertson
authors.forename: Michael
authors.initials: M
authors.lastname: Hershfield
authors.forename: Rob
authors.initials: R
authors.lastname: Sokolic
authors.forename: Fabio
authors.initials: F
authors.lastname: Candotti
authors.forename: Donald B
authors.initials: DB
authors.lastname: Kohn
mesh_terms: D000243:Adenosine Deaminase / Q000096:biosynthesis / Q000172:deficiency* / Q000235:genetics; D000293:Adolescent; D000361:Agammaglobulinemia / Q000201:enzymology / Q000235:genetics / Q000628:therapy; D064592:Autografts; D002648:Child; D002675:Child, Preschool; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015316:Genetic Therapy; D005822:Genetic Vectors; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007223:Infant; D008297:Male; D012190:Retroviridae; D016511:Severe Combined Immunodeficiency / Q000201:enzymology / Q000235:genetics / Q000628:therapy; D014161:Transduction, Genetic
chemical_list: C548482:ADA protein, human; D000243:Adenosine Deaminase